These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 8204156)

  • 1. Thrombolytic therapy for acute myocardial infarction: GUSTO criticized.
    Ogunyankin K
    N Engl J Med; 1994 Feb; 330(7):505; author reply 506. PubMed ID: 8204156
    [No Abstract]   [Full Text] [Related]  

  • 2. Thrombolytic therapy for acute myocardial infarction: GUSTO criticized.
    Chelluri L; Sirio CA; Angus DC
    N Engl J Med; 1994 Feb; 330(7):505; author reply 505-6. PubMed ID: 8289862
    [No Abstract]   [Full Text] [Related]  

  • 3. [Thrombolytic therapy in acute myocardial infarction hospitalized in a general internal medicine ward].
    Błasiak M; Zawadowicz B; Pacyk G
    Pol Tyg Lek; 1993 Apr 5-12; 48(14-15):316-7. PubMed ID: 8415244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized comparison of a novel anticoagulant, vasoflux, and heparin as adjunctive therapy to streptokinase for acute myocardial infarction: results of the VITAL study (Vasoflux International Trial for Acute Myocardial Infarction Lysis).
    Peters RJ; Spickler W; Théroux P; White H; Gibson M; Molhoek PG; Anderson HV; Weitz JI; Hirsh J; Weaver WD
    Am Heart J; 2001 Aug; 142(2):237-43. PubMed ID: 11479461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Thrombolytic therapy in acute myocardial infarct: preliminary results of a controlled clinical trial with streptokinase].
    Mannucci PM; Lotto A; Levi G; Rota M; Lomanto B; Proto C
    G Gerontol; 1971 Oct; 19(10):743-62. PubMed ID: 4946502
    [No Abstract]   [Full Text] [Related]  

  • 6. [Development and results of thrombolytic therapy].
    Deutsch E; Ebringer H; Lechner K; Pilgerstorfer HW
    Wien Med Wochenschr; 1971 May; 121(20):410-5. PubMed ID: 5566996
    [No Abstract]   [Full Text] [Related]  

  • 7. Heparin modifies platelet count and function in patients who have undergone thrombolytic therapy for acute myocardial infarction.
    Balduini CL; Noris P; Bertolino G; Previtali M
    Thromb Haemost; 1993 May; 69(5):522-3. PubMed ID: 8322276
    [No Abstract]   [Full Text] [Related]  

  • 8. [The thrombolytic therapy of recent myocardial infarctions].
    van de Loo J
    Z Gesamte Inn Med; 1965 Dec; 20(23):724-7. PubMed ID: 5333410
    [No Abstract]   [Full Text] [Related]  

  • 9. [Thrombolytic treatment with streptokinase in recent myocardial infarct].
    Pagnoni D
    Cardiol Prat; 1970 Dec; 21(6):405-9. PubMed ID: 4101064
    [No Abstract]   [Full Text] [Related]  

  • 10. Megadose heparin and streptokinase produce similar TIMI 3 flow at discharge in patients of acute myocardial infarction presenting between 7-12 hours.
    Dwivedi SK; Pramod K; Gupta R; Saran RK; Narain VS; Puri VK
    Indian Heart J; 2000; 52(2):183-6. PubMed ID: 10893895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early patency in acute myocardial infarction.
    Belenkie I
    Can J Cardiol; 1993 Mar; 9(2):149-51. PubMed ID: 8490781
    [No Abstract]   [Full Text] [Related]  

  • 12. Long-term mortality of patients with acute myocardial infarction in the United States and Canada: comparison of patients enrolled in Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries (GUSTO)-I.
    Kaul P; Armstrong PW; Chang WC; Naylor CD; Granger CB; Lee KL; Peterson ED; Califf RM; Topol EJ; Mark DB
    Circulation; 2004 Sep; 110(13):1754-60. PubMed ID: 15381645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of coronary thrombosis with streptokinase].
    Tricot R; Abastado M; Valère PE; Goglin G; Souffrant G
    Arch Mal Coeur Vaiss; 1973 May; 66(5):661-71. PubMed ID: 4199982
    [No Abstract]   [Full Text] [Related]  

  • 14. Time to treatment with thrombolytic therapy: determinants and effect on short-term nonfatal outcomes of acute myocardial infarction. Canadian GUSTO Investigators. Global Utilization of Streptokinase and + PA for Occluded Coronary Arteries.
    Cox JL; Lee E; Langer A; Armstrong PW; Naylor CD
    CMAJ; 1997 Feb; 156(4):497-505. PubMed ID: 9054819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Contribution to the thrombolytic treatment with streptokinase].
    Sochor K
    Cas Lek Cesk; 1975 Oct; 114(42):1312-3. PubMed ID: 1192457
    [No Abstract]   [Full Text] [Related]  

  • 16. Heparin as an adjuvant to thrombolytic therapy in acute myocardial infarction.
    Metz BK; Topol EJ
    Biomed Pharmacother; 1996; 50(6-7):243-53. PubMed ID: 8952863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombolytic therapy.
    Collen D
    Thromb Haemost; 1997 Jul; 78(1):742-6. PubMed ID: 9198249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The treatment of heart infarcts with thrombolytic agents].
    den Ottolander GJ; Verhey JB; Stroër-Jaarsma H
    Ned Tijdschr Geneeskd; 1966 Dec; 110(49):2159-63. PubMed ID: 5980512
    [No Abstract]   [Full Text] [Related]  

  • 19. [Thrombolytic therapy for acute myocardial infarction in the general internal medicine ward].
    Błasiak M; Pacyk G; Zawadowicz B
    Pol Tyg Lek; 1996 Mar; 51(10-13):150-2. PubMed ID: 8927550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What you should know about thrombolytic therapy for acute MI.
    Aragon D; Martin M
    Am J Nurs; 1993 Sep; 93(9):24-31; quiz 33. PubMed ID: 8213959
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.